如何看待洋地黄类正性肌力药在急性心力衰竭治疗中的作用及价值

doi:10.3969/j.issn.1002-1949.2018.01.004

Chinese Journal of Critical Care Medicine

2018, Vol. 38

Issue (1): 18-20 DOI: 10.3969/j.issn.1002-1949.2018.01.004

Abstract
Figure/Table
References (15)
Related Citation (15)

［1］Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronicheart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC［J］. Eur J Heart Fail, 2016, 18(8):891-975. ［2］俞芝江.洋地黄药物的临床应用［J］.中级医刊,1959,616：41-42. ［3］Ziff OJ, Kotecha D. Digoxin: The good and the bad［J］. Trends in Cardiovasc Med, 2016, 26 (7): 585-595. ［4］Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure［J］. N Eng J Med, 1997, 336(8): 525-533.  ［5］Patel N, Ju C, Macon C, et al. Temporal trends of digoxin use in patients hospitalized with heart failure: analysis from the American Heart Association Get With the Guidelines-Heart Failure Registry［J］. JACC Heart Fail, 2016, 4(5):348-356. ［6］van Veldhuisen DJ, Van Gelder IC, Ahmed A, et al. Digoxin for patients with atrial fibrillation and heart failure: paradise lost or not［J］. Eur Heart J, 2013, 34(20): 1468-1470. ［7］Stucky MA, Goldberger ZD. Digoxin: its role in contemporary medicine［J］. Postgrad Med J, 2015, 91(1079): 514-518. ［8］Adams KF Jr, Butler J, Patterson JH, et al. Dose response characterization of the association of serum digoxin concentration with mortality outcomes in the Digitalis Investigation Group trial［J］. Eur J Heart Fail, 2016,18(8):1072-1081. ［9］Milton Packe. Why is the use of digitalis withering［J］. Eur J Heart Fail, 2017.doi:10.1002/ejhf.1043. ［10］李茂堂. 洋地黄化的概念［J］.中国乡村医生杂志, 1986, 8:34-35. ［11］佐藤友英.洋地黄疗法的进展［J］.最新医学, 1980, 1:51. ［12］朱俊. 心力衰竭的进展——（7）心功能不全：正性肌力药物的地位正在变化（续4）［J］. 中国循环杂志, 2006, 21(3): 163-164.  ［13］Muniz-Junqueira MI, Mota LM, Aires RB, et al. Digitalis inhibits and furosemide does not change the in vitro phagocytic function of neutrophilsof healthy subjects［J］.Int Immunopharmacol, 2003, 3(10-11) :1439-1445. ［14］Adams KF Jr, Ghali JK, Herbert PJ, et al. A perspective on re-evaluating digoxin′s role in the current management of patients with chronic systolic heart failure:targeting serum concentration to reduce hospitalization and improve safety profile［J］. Eur J Heart Fail, 2014, 16(5): 483-493. ［15］Mittal MK, Chockalingam P, Chockalingam A. Contemporary indications and therapeutic implications for digoxin use［J］. Am J Ther, 2011,18(4): 280-287.